Clinical Trials Directory

Trials / Completed

CompletedNCT05985018

Traditional Dietary Advice Vs. Mediterranean Diet in IBS

A Randomized Trial of Traditional Dietary Advice Versus Mediterranean Diet in Irritable Bowel Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
139 (actual)
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Irritable bowel syndrome (IBS) affects 5-10% of the population, and incurs substantial health impairment and healthcare utilization. Over 80% of individuals with IBS report food to trigger or aggravate symptoms, with many seeking to undertake dietary modifications. Current guidelines recommend first-line therapy with the relatively straightforward traditional dietary advice, with the more complex and restrictive low FODMAP diet reserved as second-line therapy. There is emerging data suggesting that the Mediterranean diet may also improve the symptoms of IBS, although it has not yet been subject to any head-to-head randomized dietary trials to help position it within the treatment algorithm. Given the relative ease of implementing the Mediterranean diet, alongside its recognized cardio-metabolic and mental health benefits, studying its efficacy in IBS is attractive as it could potentially pave the way for another first-line dietary option being available to patients before escalating to the demanding and resource intensive second-line therapies. The investigators will perform a randomized trial comparing the clinical efficacy of traditional dietary advice vs. a Mediterranean diet in IBS. Following dietary randomization, participants will complete validated questionnaires to assess changes in IBS symptoms, quality of life, mood, somatic symptoms, nutritional status, as well as dietary satisfaction and adherence.

Conditions

Interventions

TypeNameDescription
OTHERTraditional DietProvided as an educational leaflet
OTHERMediterranean DietProvided as an educational leaflet

Timeline

Start date
2023-09-30
Primary completion
2024-12-20
Completion
2024-12-20
First posted
2023-08-09
Last updated
2025-03-14

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05985018. Inclusion in this directory is not an endorsement.